https://www.selleckchem.com/pr....oducts/filanesib.htm
3(8.2)% and - 1.2(7.5)% for the dapagliflozin and glibenclamide arms, respectively (p = 0.0001). Differences between study arms in the second coprimary endpoint were not significant. Plasma nitrite 1min after rest FMD was higher for dapagliflozin [308(22 nmol/L] than for glibenclamide (258[110] nmol/L; p = 0.028). The resistive indices at 1min [0.90 (0.11) vs. 0.93 (0.07); p = 0.03] and 5min [0.93 (0.07) vs. 0.95 (0.05); p = 0.02] were higher for the glibenclamide group than for the dapagliflozin group. Plasma biomarkers for inflamm
Like
Comment
Share
